ProteLight Pharma’s Peceleganan (PL-5) Accepted for Review by China’s CDE
China’s Center for Drug Evaluation (CDE) website has indicated that a market filing by local...
Innovent Biologics Partners with Suzhou ForLong to Explore Sintilimab and FL115 Combination in Solid Tumors
China-based Innovent Biologics, Inc. (HKG: 1801) has announced a clinical study and supply agreement with...
Zhejiang Huahai Pharmaceutical’s Subsidiary Huaota Bio Secures $27.4 Million Investment
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) has announced that its macromolecular drug-focused subsidiary, Shanghai...
Bristol-Myers Squibb’s Sotyktu Meets Primary Endpoints in POETYK PsA Studies
US pharmaceutical major Bristol-Myers Squibb (BMS; NYSE: BMY) has announced positive results from the pivotal...
Bio-Thera Solutions Enters Licensing Agreement with Tabuk Pharmaceutical for BAT2206 in Saudi Arabia
China-based Bio-Thera Solutions (SHA: 688177) has announced a licensing agreement with Tabuk Pharmaceutical Manufacturing Company,...
Achilles Therapeutics and AstraZeneca Seal $12 Billion Deal for TRACERx NSCLC Study Data
UK-based Achilles Therapeutics plc has announced a landmark deal worth USD 12 billion with AstraZeneca...
Nuvation Bio’s Taletrectinib NDA for ROS1+ NSCLC Receives FDA Priority Review
US-based Nuvation Bio Inc. (NYSE: NUVB) has announced that the New Drug Application (NDA) for...
Shanghai Henlius Biotech Initiates Patient Dosing in Global Phase III ELAINE-3 Study for Lasofoxifene
Shanghai Henlius Biotech Inc., (HKG: 2696), a leading biopharmaceutical company based in China, has announced...
RaysightMed’s AngioQFA 100 Receives NMPA Approval for Coronary Artery Function Measurement
China-based RaysightMed Co., Ltd has announced that it has received marketing approval from the National...
uBriGene Secures RMB 200 Million in Pre-Series D Financing to Expand ATMPs CDMO Services
China-based uBriGene, a contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products...
WuXi AppTec to Divest WuXi Advanced Therapies and Oxford Genetics to Altaris LLC
China-based Contract Development and Manufacturing Organization (CDMO) WuXi AppTec Co., Ltd (SHA: 603259) has announced...
Basecare Medical and SolarCare Form Alliance to Advance AI in IVF Services
Suzhou Basecare Medical Co., Ltd (HKG: 2170), a leading China-based in vitro fertilization (IVF) specialist,...
Alphamab Oncology’s JSKN033 Gets Green Light for Phase I/II Study from China’s CDE
China-based Alphamab Oncology (HKG: 9966) has announced that it has received approval from the Center...
CSPC Pharmaceutical’s SYH2062 Receives NMPA Clearance for Hypertension Treatment
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that it has received clinical...
Keymed Biosciences’ Kangyueda Approved for CRSwNP Treatment in China
China-based Keymed Biosciences Inc., (HKG: 2162) has announced that it has received another indication approval...
Sichuan Biokin’s GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a China-based pharmaceutical company, has announced that it...
Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial
China-based Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has received the green...
AstraZeneca’s Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced that the European Commission (EU) has...
Ikena Oncology and Inmagene Biopharmaceuticals to Merge into ImageneBio, Listed on Nasdaq as ‘IMA’
US-based Ikena Oncology, Inc. (NASDAQ: IKNA) and Sino-US biotech Inmagene Biopharmaceuticals have announced their merger...
Sanofi and SK bioscience Broaden Partnership to Develop Next-Gen Pneumococcal Vaccines
French pharmaceutical major Sanofi (NASDAQ: SNY) and South Korea-based SK bioscience (KRX: 302440) have announced...